GlassScriptPhysician profile
Kurt A Mildenstein
NPI 1619238276
$3,277.28
in general payments reported to CMS, 2019-2025
40 companies · $628 in 2025
The $628 reported for 2025 was more than what 82% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $288 · 2021: $413 · 2022: $452 · 2023: $396 · 2024: $740 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $666.89 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $358.16 | 2023-2025 | Dysport |
| Collegium Pharmaceutical, INC. | $255.11 | 2019-2025 | Belbuca |
| Teva Pharmaceuticals USA, INC. | $186.98 | 2019-2022 | |
| Vertos Medical, INC. | $161.88 | 2022 | |
| Allergan, INC. | $158.50 | 2019-2021 | |
| Averitas Pharma INC. | $144.26 | 2024-2025 | Qutenza |
| Boston Scientific Corporation | $123.14 | 2019-2025 | Intracept, General - Pain Management |
| Medtronic, INC. | $95.82 | 2023-2024 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Amgen INC. | $91.16 | 2021-2022 | |
| Pfizer INC. | $69.26 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.66 | 2022-2024 | Relistor |
| Abbott Laboratories | $64.45 | 2019-2023 | Proclaim |
| Pacira Therapeutics, INC. | $61.12 | 2019-2020 | |
| Hydrocision, INC. | $57.39 | 2024 | Tenjet |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Mildenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.